Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Ovary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07462468
What this trial is testing

Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With Platinum-resistant Recurrent Ovarian Cancer.

Who this might be right for
Platinum-resistant Recurrent Ovarian Cancer (PROC)
WestVac Biopharma Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT00267696
What this trial is testing

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Ohio State University Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT06023862
What this trial is testing

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more
Yonsei University 198
Early research (Phase 1)Temporarily pausedNCT00753480
What this trial is testing

D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cancer
Genentech, Inc. 56
Early research (Phase 1)Study completedNCT01673217
What this trial is testing

Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00002515
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorHead and Neck Cancer+8 more
Memorial Sloan Kettering Cancer Center
Very early researchUnknownNCT03814447
What this trial is testing

The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Shanghai 6th People's Hospital 10
Early research (Phase 1)Study completedNCT00357448
What this trial is testing

Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid Adenocarcinoma+8 more
University of Washington 11
Testing effectiveness (Phase 2)Ended earlyNCT06257758
What this trial is testing

VIO-01 in Participants With Recurrent Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsBreast CancerRecurrent Ovarian Cancer+1 more
Valerio Therapeutics 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06552858
What this trial is testing

Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Fudan University 30
Not applicableStudy completedNCT00804258
What this trial is testing

Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
City of Hope Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT00889382
What this trial is testing

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Who this might be right for
Ovarian CancerSolid Tumors
Astellas Pharma Inc 152
Large-scale testing (Phase 3)Not Yet RecruitingNCT06867562
What this trial is testing

Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer

Who this might be right for
Platinum-Resistant Primary Peritoneal CarcinomaPlatinum Resistant High Grade Epithelial Ovarian CancerPlatinum Resistant High Grade Serous Ovarian Cancer
Jina Pharmaceuticals Inc. 166
Testing effectiveness (Phase 2)Study completedNCT00429559
What this trial is testing

Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

Who this might be right for
Ovarian Cancer
Hellenic Oncology Research Group 31
Testing effectiveness (Phase 2)Study completedNCT01188876
What this trial is testing

Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Massachusetts General Hospital 50
Not applicableEnded earlyNCT00900068
What this trial is testing

Blood Samples From Patients on a Clinical Trial to CINV During HSCT

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT00278343
What this trial is testing

Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Ended earlyNCT02389985
What this trial is testing

CRLX101(NLG207) in Combination With Weekly Paclitaxel in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer
NewLink Genetics Corporation 30
Not applicableUnknownNCT03717610
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy for Treatment of Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer Recurrent
Uppsala University Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT05113368
What this trial is testing

Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer

Who this might be right for
Ovarian CancerSerous Ovarian Cancer
Sarah K. Lynam MD 31
Next Page